• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人线粒体脱氧鸟苷激酶对抗癌核苷类似物的磷酸化作用。

Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.

作者信息

Zhu C, Johansson M, Permert J, Karlsson A

机构信息

Division of Clinical Virology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

出版信息

Biochem Pharmacol. 1998 Oct 15;56(8):1035-40. doi: 10.1016/s0006-2952(98)00150-6.

DOI:10.1016/s0006-2952(98)00150-6
PMID:9776315
Abstract

The kinetic properties of recombinant human mitochondrial deoxyguanosine kinase (dGK, EC 2.7.1.113) for 2'-deoxyguanosine and the clinically important nucleoside analogs 2-chloro-2'-deoxyadenosine (CdA), 9-beta-D-arabinofuranosylguanine (araG) and 2',2',-difluorodeoxyguanosine (dFdG) were determined. The Michaelis-Menten kinetic parameters, comparing ATP and UTP as phosphate donors, demonstrated a marked increase in phosphorylation efficiency (VmaxKm) with UTP in comparison with ATP for both CdA and araG. The difluoro analog dFdG was an efficient substrate for recombinant dGK with an apparent Km of 16 microM with ATP as phosphate donor. We compared the kinetic properties of dGK with those of the related enzyme deoxycytidine kinase (dCK, EC 2.7.1.74). Although the purines 2'-deoxyguanosine (dGuo) and 2'-deoxyadenosine are substrates for both dGK and dCK, only CdA among the purine nucleoside analogs tested was an efficient substrate for both dCK and dGK. In competition with dGuo, the most efficient analog for phosphorylation by dGK was araG, as indicated by a lower Ki value than for CdA and dFdG. Of the purine analogs tested as substrates for dCK, only CdA could compete with 2'-deoxycytidine (dCyd). No inhibition of dCK-mediated dCyd phosphorylation was found by either araG or dFdG. In crude cell extract of HeLa and Capan 2 cells, the major CdA phosphorylation was contributed by dCK, while most araG phosphorylation was a result of dGK activity. Our study with pure recombinant enzymes confirms that dGK is mainly responsible for araG and dFdG phosphorylation, whereas dCK is the most important enzyme for activation of CdA and 2',2'-difluorodeoxycytidine (dFdC).

摘要

测定了重组人线粒体脱氧鸟苷激酶(dGK,EC 2.7.1.113)对2'-脱氧鸟苷以及临床上重要的核苷类似物2-氯-2'-脱氧腺苷(CdA)、9-β-D-阿拉伯呋喃糖基鸟嘌呤(araG)和2',2'-二氟脱氧鸟苷(dFdG)的动力学性质。米氏动力学参数表明,以ATP和UTP作为磷酸供体时,与ATP相比,UTP使CdA和araG的磷酸化效率(Vmax/Km)显著提高。二氟类似物dFdG是重组dGK的有效底物,以ATP作为磷酸供体时其表观Km为16 μM。我们比较了dGK与相关酶脱氧胞苷激酶(dCK,EC 2.7.1.74)的动力学性质。虽然嘌呤2'-脱氧鸟苷(dGuo)和2'-脱氧腺苷是dGK和dCK的底物,但在所测试的嘌呤核苷类似物中,只有CdA是dCK和dGK的有效底物。在与dGuo竞争时,dGK磷酸化最有效的类似物是araG,其Ki值低于CdA和dFdG。在所测试的作为dCK底物的嘌呤类似物中,只有CdA能与2'-脱氧胞苷(dCyd)竞争。araG或dFdG均未发现对dCK介导的dCyd磷酸化有抑制作用。在HeLa和Capan 2细胞的粗细胞提取物中,CdA的主要磷酸化由dCK贡献,而大多数araG磷酸化是dGK活性的结果。我们对纯重组酶的研究证实,dGK主要负责araG和dFdG的磷酸化,而dCK是激活CdA和2',2'-二氟脱氧胞苷(dFdC)的最重要酶。

相似文献

1
Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.人线粒体脱氧鸟苷激酶对抗癌核苷类似物的磷酸化作用。
Biochem Pharmacol. 1998 Oct 15;56(8):1035-40. doi: 10.1016/s0006-2952(98)00150-6.
2
Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines.通过在癌细胞系中过表达线粒体脱氧鸟苷激酶增强核苷类似物的细胞毒性。
J Biol Chem. 1998 Jun 12;273(24):14707-11. doi: 10.1074/jbc.273.24.14707.
3
Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.纯重组人脱氧胞苷激酶和小鼠脱氧胞苷激酶动力学特性的差异。
Biochem Pharmacol. 1995 Jul 17;50(2):163-8. doi: 10.1016/0006-2952(95)00129-n.
4
Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine.线粒体2'-脱氧鸟苷激酶的底物特异性。2-氯脱氧腺苷的高效磷酸化。
J Biol Chem. 1993 Oct 25;268(30):22847-52.
5
Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs.人脱氧胞苷激酶和人脱氧鸟苷激酶对2'-脱氧腺苷、2'-脱氧鸟苷及其类似物的对映体选择性较低。
Biochimie. 1999 Nov;81(11):1041-7. doi: 10.1016/s0300-9084(99)00331-4.
6
Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs.人重组线粒体脱氧鸟苷激酶对具有细胞抑制和抗病毒作用的嘌呤及嘧啶类似物的底物特异性。
Mol Pharmacol. 1998 Feb;53(2):270-3. doi: 10.1124/mol.53.2.270.
7
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.阿拉伯糖基鸟嘌呤可被胞质脱氧胞苷激酶和线粒体脱氧鸟苷激酶磷酸化。
Cancer Res. 2002 Jun 1;62(11):3100-5.
8
Stereoisomeric selectivity of human deoxyribonucleoside kinases.人类脱氧核糖核苷激酶的立体异构选择性。
Biochemistry. 1999 Dec 21;38(51):16993-9. doi: 10.1021/bi9908843.
9
RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.人白血病CEM细胞中脱氧胞苷激酶和脱氧鸟苷激酶的RNA干扰缺失
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):712-9. doi: 10.1080/15257770802145231.
10
Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells.二氟脱氧鸟苷:对人白血病细胞的细胞毒性、代谢及对DNA合成的作用
Semin Oncol. 1995 Aug;22(4 Suppl 11):61-7.

引用本文的文献

1
Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-action.奈拉滨用于T细胞急性淋巴细胞白血病:细胞内代谢及分子作用机制
Leukemia. 2025 Mar;39(3):531-542. doi: 10.1038/s41375-025-02529-2. Epub 2025 Feb 17.
2
Widely targeted metabolomics reveals the antioxidant and anticancer activities of different colors of .广泛靶向代谢组学揭示了不同颜色的……的抗氧化和抗癌活性。 (原文中“of different colors of.”表述不完整,可能存在信息缺失)
Front Nutr. 2023 May 19;10:1166375. doi: 10.3389/fnut.2023.1166375. eCollection 2023.
3
Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination.
通过同源重组修复新型核苷类似物 CNDAG 诱导的 DNA 损伤。
Cancer Chemother Pharmacol. 2020 Apr;85(4):661-672. doi: 10.1007/s00280-020-04035-x. Epub 2020 Feb 18.
4
Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine.β-D-6-环丙氨基-2',3'-二脱氢-2',3'-二脱氧鸟苷抗人免疫缺陷病毒活性的机制
Antimicrob Agents Chemother. 2005 May;49(5):1994-2001. doi: 10.1128/AAC.49.5.1994-2001.2005.
5
Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.人脱氧核糖核苷激酶和核糖核苷激酶对抗病毒和抗癌核苷类似物的底物特异性及磷酸化作用
Pharmacol Ther. 2003 Nov;100(2):119-39. doi: 10.1016/j.pharmthera.2003.07.001.
6
The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals.人类线粒体脱氧核苷酸载体及其在核苷类抗病毒药物毒性中的作用。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2284-8. doi: 10.1073/pnas.031430998. Epub 2001 Feb 20.
7
Antiviral guanosine analogs as substrates for deoxyguanosine kinase: implications for chemotherapy.作为脱氧鸟苷激酶底物的抗病毒鸟苷类似物:对化疗的影响。
Antimicrob Agents Chemother. 2001 Mar;45(3):739-42. doi: 10.1128/AAC.45.3.739-742.2001.
8
Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice.免疫缺陷的线粒体基础。来自嘌呤核苷磷酸化酶缺陷小鼠的证据。
J Exp Med. 2000 Jun 19;191(12):2197-208. doi: 10.1084/jem.191.12.2197.